Cargando…

갑상선암에 대한 고주파 절제 적용의 과거, 현재, 그리고 미래

Thyroid cancer, characterized by high incidence rates, good prognosis, and frequent recurrence, is typically treated surgically. However, since the early 2000s, radiofrequency ablation, which is commonly utilized in liver, lung, and kidney cancers, is being performed for management of primary and re...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Radiology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585085/
https://www.ncbi.nlm.nih.gov/pubmed/37869115
http://dx.doi.org/10.3348/jksr.2023.0075
_version_ 1785122877393076224
collection PubMed
description Thyroid cancer, characterized by high incidence rates, good prognosis, and frequent recurrence, is typically treated surgically. However, since the early 2000s, radiofrequency ablation, which is commonly utilized in liver, lung, and kidney cancers, is being performed for management of primary and recurrent thyroid cancers. Many studies have focused on inoperable cases of low-risk papillary microcarcinoma (≤ 1 cm) and some have investigated its role in larger lesions (up to 4 cm). Overall, these studies have reported positive results. Radiofrequency ablation for recurrent cancer has primarily been performed for locally recurrent cervical cancer, and this therapeutic approach has been attempted for treatment of distant metastases in lungs and bones, with encouraging outcomes. A growing global trend, particularly in South Korea, the United States, and Europe supports radiofrequency ablation for thyroid cancer. However, this therapy is currently not recognized as a treatment option recommended by universally accepted clinical guidelines such as those established by the National Comprehensive Cancer Network. Based on past efforts and future research, radiofrequency ablation is expected to play a key role in thyroid cancer treatment in the near future.
format Online
Article
Text
id pubmed-10585085
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Korean Society of Radiology
record_format MEDLINE/PubMed
spelling pubmed-105850852023-10-20 갑상선암에 대한 고주파 절제 적용의 과거, 현재, 그리고 미래 J Korean Soc Radiol Clinical Application of Thyroid Radiofrequency Ablation: Present and Future Thyroid cancer, characterized by high incidence rates, good prognosis, and frequent recurrence, is typically treated surgically. However, since the early 2000s, radiofrequency ablation, which is commonly utilized in liver, lung, and kidney cancers, is being performed for management of primary and recurrent thyroid cancers. Many studies have focused on inoperable cases of low-risk papillary microcarcinoma (≤ 1 cm) and some have investigated its role in larger lesions (up to 4 cm). Overall, these studies have reported positive results. Radiofrequency ablation for recurrent cancer has primarily been performed for locally recurrent cervical cancer, and this therapeutic approach has been attempted for treatment of distant metastases in lungs and bones, with encouraging outcomes. A growing global trend, particularly in South Korea, the United States, and Europe supports radiofrequency ablation for thyroid cancer. However, this therapy is currently not recognized as a treatment option recommended by universally accepted clinical guidelines such as those established by the National Comprehensive Cancer Network. Based on past efforts and future research, radiofrequency ablation is expected to play a key role in thyroid cancer treatment in the near future. The Korean Society of Radiology 2023-09 2023-09-16 /pmc/articles/PMC10585085/ /pubmed/37869115 http://dx.doi.org/10.3348/jksr.2023.0075 Text en Copyrights © 2023 The Korean Society of Radiology https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Application of Thyroid Radiofrequency Ablation: Present and Future
갑상선암에 대한 고주파 절제 적용의 과거, 현재, 그리고 미래
title 갑상선암에 대한 고주파 절제 적용의 과거, 현재, 그리고 미래
title_full 갑상선암에 대한 고주파 절제 적용의 과거, 현재, 그리고 미래
title_fullStr 갑상선암에 대한 고주파 절제 적용의 과거, 현재, 그리고 미래
title_full_unstemmed 갑상선암에 대한 고주파 절제 적용의 과거, 현재, 그리고 미래
title_short 갑상선암에 대한 고주파 절제 적용의 과거, 현재, 그리고 미래
title_sort 갑상선암에 대한 고주파 절제 적용의 과거, 현재, 그리고 미래
topic Clinical Application of Thyroid Radiofrequency Ablation: Present and Future
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585085/
https://www.ncbi.nlm.nih.gov/pubmed/37869115
http://dx.doi.org/10.3348/jksr.2023.0075
work_keys_str_mv AT gabsangseonamedaehangojupajeoljejeogyonguigwageohyeonjaegeuligomilae